San Francisco, Calif.-based InsightRX’s Nova cloud-based dosing software platform has received a CE mark.

The Nova software develops pharmacological profiles using patient-specific data along with population-wide pharmacokinetic information, drug monitoring and Bayesian statistical forecasting.

The machine learning platform combines all the information to help clinicians understand each patient’s pharmacological profile and optimize dosing.